AAAAAA

   
Results: 1-25 | 26-37 |
Results: 26-37/37
EVALUATION AND MANAGEMENT OF RADIATION-INDUCED THYROID AND PARATHYROID ABNORMALITIES
Authors: VASSILOPOULOUSELLIN R
Citation: R. Vassilopoulousellin, EVALUATION AND MANAGEMENT OF RADIATION-INDUCED THYROID AND PARATHYROID ABNORMALITIES, The Journal of clinical endocrinology and metabolism, 80(5), 1995, pp. 1753-1753
ISLET-CELL TUMORS OF THE PANCREAS
Authors: VASSILOPOULOUSELLIN R AJANI J
Citation: R. Vassilopoulousellin et J. Ajani, ISLET-CELL TUMORS OF THE PANCREAS, Endocrinology and metabolism clinics of North America, 23(1), 1994, pp. 53-65
PLEURAL EFFUSION IN PATIENTS WITH DIFFERENTIATED PAPILLARY THYROID-CANCER
Authors: VASSILOPOULOUSELLIN R SNEIGE N
Citation: R. Vassilopoulousellin et N. Sneige, PLEURAL EFFUSION IN PATIENTS WITH DIFFERENTIATED PAPILLARY THYROID-CANCER, Southern medical journal, 87(11), 1994, pp. 1111-1116
MANAGEMENT OF MENOPAUSE IN WOMEN WITH HISTORY OF BREAST-CANCER - STUDY DESIGN AND PATIENT SELECTION FOR A PROSPECTIVE, RANDOMIZED CLINICAL-TRIAL
Authors: VASSILOPOULOUSELLIN R HORTOBAGYI GH MCNEESE MD SINGLETARY ES SMITH TL THERIAULT RL
Citation: R. Vassilopoulousellin et al., MANAGEMENT OF MENOPAUSE IN WOMEN WITH HISTORY OF BREAST-CANCER - STUDY DESIGN AND PATIENT SELECTION FOR A PROSPECTIVE, RANDOMIZED CLINICAL-TRIAL, Clinical research, 42(3), 1994, pp. 10000432-10000432
IMPACT OF ADJUVANT MITOTANE ON THE CLINICAL COURSE OF PATIENTS WITH ADRENOCORTICAL CANCER - REPLY
Authors: VASSILOPOULOUSELLIN R GUINEE VF TAYLOR SH HESS KR
Citation: R. Vassilopoulousellin et al., IMPACT OF ADJUVANT MITOTANE ON THE CLINICAL COURSE OF PATIENTS WITH ADRENOCORTICAL CANCER - REPLY, Cancer, 73(5), 1994, pp. 1534-1535
MITOTANE IN ADRENOCORTICAL CARCINOMA
Authors: VASSILOPOULOUSELLIN R GUINEE VF
Citation: R. Vassilopoulousellin et Vf. Guinee, MITOTANE IN ADRENOCORTICAL CARCINOMA, British Journal of Cancer, 70(4), 1994, pp. 779-779
METASTATIC THYROID-CANCER - REPLY
Authors: VASSILOPOULOUSELLIN R WEBER RS
Citation: R. Vassilopoulousellin et Rs. Weber, METASTATIC THYROID-CANCER - REPLY, Head & neck, 15(4), 1993, pp. 357-358
INTERLEUKIN-2 INDUCED THYROID-DYSFUNCTION IS CORRELATED WITH TREATMENT DURATION BUT NOT WITH TUMOR RESPONSE
Authors: VASSILOPOULOUSELLIN R SELLA A
Citation: R. Vassilopoulousellin et A. Sella, INTERLEUKIN-2 INDUCED THYROID-DYSFUNCTION IS CORRELATED WITH TREATMENT DURATION BUT NOT WITH TUMOR RESPONSE, Journal of clinical oncology, 11(8), 1993, pp. 1626-1626
ESTROGEN REPLACEMENT THERAPY IN WOMEN AT INCREASED RISK FOR BREAST-CANCER
Authors: VASSILOPOULOUSELLIN R
Citation: R. Vassilopoulousellin, ESTROGEN REPLACEMENT THERAPY IN WOMEN AT INCREASED RISK FOR BREAST-CANCER, Breast cancer research and treatment, 28(2), 1993, pp. 167-177
OVARIAN-FUNCTION AND FERTILITY AFTER CHEMOTHERAPY (NOVANTRONE, ONCOVIN, VINBLASTINE AND PREDNISONE-NOVP) AND RADIOTHERAPY (RT) FOR HODGKINS-DISEASE
Authors: LAREMORE DM HAGEMEISTER FB VASSILOPOULOUSELLIN R
Citation: Dm. Laremore et al., OVARIAN-FUNCTION AND FERTILITY AFTER CHEMOTHERAPY (NOVANTRONE, ONCOVIN, VINBLASTINE AND PREDNISONE-NOVP) AND RADIOTHERAPY (RT) FOR HODGKINS-DISEASE, Clinical research, 41(4), 1993, pp. 10000726-10000726
INCIDENCE OF HYPERCALCEMIA IN PATIENTS WITH MALIGNANCY REFERRED TO A COMPREHENSIVE CANCER CENTER - REPLY
Authors: VASSILOPOULOUSELLIN R
Citation: R. Vassilopoulousellin, INCIDENCE OF HYPERCALCEMIA IN PATIENTS WITH MALIGNANCY REFERRED TO A COMPREHENSIVE CANCER CENTER - REPLY, Cancer, 72(3), 1993, pp. 956-957
IMPACT OF ADJUVANT MITOTANE ON THE CLINICAL COURSE OF PATIENTS WITH ADRENOCORTICAL CANCER
Authors: VASSILOPOULOUSELLIN R GUINEE VF KLEIN MJ TAYLOR SH HESS KR SCHULTZ PN SAMAAN NA
Citation: R. Vassilopoulousellin et al., IMPACT OF ADJUVANT MITOTANE ON THE CLINICAL COURSE OF PATIENTS WITH ADRENOCORTICAL CANCER, Cancer, 71(10), 1993, pp. 3119-3123
Risultati: 1-25 | 26-37 |